157 related articles for article (PubMed ID: 25970657)
1. Pediatric second primary malignancies after retinoblastoma treatment.
Temming P; Viehmann A; Arendt M; Eisele L; Spix C; Bornfeld N; Sauerwein W; Jöckel KH; Lohmann DR
Pediatr Blood Cancer; 2015 Oct; 62(10):1799-804. PubMed ID: 25970657
[TBL] [Abstract][Full Text] [Related]
2. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
[TBL] [Abstract][Full Text] [Related]
3. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma.
Ketteler P; Hülsenbeck I; Frank M; Schmidt B; Jöckel KH; Lohmann DR
Eur J Cancer; 2020 Jul; 133():47-55. PubMed ID: 32434110
[TBL] [Abstract][Full Text] [Related]
4. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
5. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
6. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
Shinohara ET; DeWees T; Perkins SM
Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
[TBL] [Abstract][Full Text] [Related]
7. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
8. Pediatric solid tumors and second malignancies: characteristics and survival outcomes.
Vasudevan V; Cheung MC; Yang R; Zhuge Y; Fischer AC; Koniaris LG; Sola JE
J Surg Res; 2010 May; 160(2):184-9. PubMed ID: 19765728
[TBL] [Abstract][Full Text] [Related]
9. Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Savage P; Cooke R; O'Nions J; Krell J; Kwan A; Camarata M; Dancy G; Short D; Seckl MJ; Swerdlow A
J Clin Oncol; 2015 Feb; 33(5):472-8. PubMed ID: 25547507
[TBL] [Abstract][Full Text] [Related]
10. Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.
Ishida Y; Qiu D; Maeda M; Fujimoto J; Kigasawa H; Kobayashi R; Sato M; Okamura J; Yoshinaga S; Rikiishi T; Shichino H; Kiyotani C; Kudo K; Asami K; Hori H; Kawaguchi H; Inada H; Adachi S; Manabe A; Kuroda T
Int J Clin Oncol; 2016 Jun; 21(3):506-16. PubMed ID: 26620038
[TBL] [Abstract][Full Text] [Related]
11. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.
Abramson DH; Frank CM
Ophthalmology; 1998 Apr; 105(4):573-9; discussion 579-80. PubMed ID: 9544627
[TBL] [Abstract][Full Text] [Related]
12. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
13. Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan.
Araki Y; Matsuyama Y; Kobayashi Y; Toyokawa S; Inoue K; Suzuki S; Makimoto A
Jpn J Clin Oncol; 2011 Mar; 41(3):373-9. PubMed ID: 21051531
[TBL] [Abstract][Full Text] [Related]
14. [Retinoblatoma: a review].
Doz F
Arch Pediatr; 2006 Oct; 13(10):1329-37. PubMed ID: 16930963
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
[TBL] [Abstract][Full Text] [Related]
16. Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.
Habib LA; Francis JH; Fabius AW; Gobin PY; Dunkel IJ; Abramson DH
Br J Ophthalmol; 2018 Feb; 102(2):272-275. PubMed ID: 28600304
[TBL] [Abstract][Full Text] [Related]
17. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy.
Mohney BG; Robertson DM; Schomberg PJ; Hodge DO
Am J Ophthalmol; 1998 Aug; 126(2):269-77. PubMed ID: 9727521
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
[TBL] [Abstract][Full Text] [Related]
19. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013.
Gregersen PA; Olsen MH; Urbak SF; Funding M; Dalton SO; Overgaard J; Alsner J
JAMA Netw Open; 2020 Oct; 3(10):e2022126. PubMed ID: 33090227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
